SE7413530L - - Google Patents

Info

Publication number
SE7413530L
SE7413530L SE7413530A SE7413530A SE7413530L SE 7413530 L SE7413530 L SE 7413530L SE 7413530 A SE7413530 A SE 7413530A SE 7413530 A SE7413530 A SE 7413530A SE 7413530 L SE7413530 L SE 7413530L
Authority
SE
Sweden
Prior art keywords
member selected
group consiting
alkyl
carbon atoms
methylene
Prior art date
Application number
SE7413530A
Other languages
English (en)
Other versions
SE412389B (sv
Inventor
Michiro Inoue
Masayuki Ishikawa
Takashi Tsuchiya
Takio Shimamoto
Original Assignee
Michiro Inoue
Masayuki Ishikawa
Takashi Tsuchiya
Takio Shimamoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12126073A external-priority patent/JPS5732065B2/ja
Priority claimed from JP12175773A external-priority patent/JPS5724786B2/ja
Application filed by Michiro Inoue, Masayuki Ishikawa, Takashi Tsuchiya, Takio Shimamoto filed Critical Michiro Inoue
Publication of SE7413530L publication Critical patent/SE7413530L/xx
Publication of SE412389B publication Critical patent/SE412389B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7413530A 1973-10-30 1974-10-28 Forfarande for framstellning av 1-ftalazon-derivat. SE412389B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12126073A JPS5732065B2 (cs) 1973-10-30 1973-10-30
JP12175773A JPS5724786B2 (cs) 1973-10-31 1973-10-31

Publications (2)

Publication Number Publication Date
SE7413530L true SE7413530L (cs) 1975-05-02
SE412389B SE412389B (sv) 1980-03-03

Family

ID=26458679

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413530A SE412389B (sv) 1973-10-30 1974-10-28 Forfarande for framstellning av 1-ftalazon-derivat.

Country Status (20)

Country Link
US (1) US3963716A (cs)
AR (1) AR205004A1 (cs)
CA (1) CA1029377A (cs)
CH (2) CH610892A5 (cs)
DD (1) DD119231A5 (cs)
DE (1) DE2451417C3 (cs)
DK (1) DK134345B (cs)
ES (1) ES431454A1 (cs)
FI (1) FI59402C (cs)
FR (1) FR2248841B1 (cs)
GB (1) GB1459606A (cs)
HU (1) HU168797B (cs)
IE (1) IE39831B1 (cs)
IL (1) IL45675A (cs)
IN (1) IN139552B (cs)
LU (1) LU71191A1 (cs)
NL (1) NL7414186A (cs)
PH (1) PH10519A (cs)
SE (1) SE412389B (cs)
YU (1) YU289774A (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120960A (en) * 1973-10-31 1978-10-17 The Boots Company Limited Therapeutic agents
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
US4464532A (en) * 1979-07-31 1984-08-07 Nippon Kayaku Kabushiki Kaisha Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
JPS5668609A (en) * 1979-11-07 1981-06-09 Nippon Kayaku Co Ltd Phthalazinol preparation
JPS58116471A (ja) * 1981-12-29 1983-07-11 Nippon Kayaku Co Ltd ４−ヒドロキシメチル−１−フタラゾンエステル誘導体およびその塩
GB2127805A (en) * 1982-09-13 1984-04-18 Showa Denko Kk Phthalazones
US4861778A (en) * 1986-06-16 1989-08-29 Research Corporation 2,3-dihydrophthalazine-1,4-diones
US5177075A (en) * 1988-08-19 1993-01-05 Warner-Lambert Company Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
ATE117553T1 (de) * 1988-08-19 1995-02-15 Warner Lambert Co Substituierte dihydroisochinolinone und verwandte verbindungen als verstärker der letalen effekte von bestrahlung und bestimmten chemotherapeutika; ausgewählte verbindungen, analoga und verfahren.
DE4345266C2 (de) * 1993-10-04 1996-12-19 Luitpold Pharma Gmbh Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel
RU2169139C1 (ru) * 2000-08-02 2001-06-20 Закрытое акционерное общество "Центр современной медицины "Медикор" Способ получения щелочных и щелочноземельных солей 5-амино-2,3-дигидро-1,4-фталазиндиона
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2011059053A1 (ja) 2009-11-13 2011-05-19 東レ株式会社 糖尿病の治療または予防薬
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012118972A2 (en) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116430B2 (cs) * 1971-08-05 1976-05-24
US3870792A (en) * 1972-07-24 1975-03-11 Michiro Inoue Certain dihydrophthalizines for treating hemorrhage and thrombosis

Also Published As

Publication number Publication date
IL45675A0 (en) 1974-11-29
IE39831B1 (en) 1979-01-03
NL7414186A (nl) 1975-05-02
FR2248841B1 (cs) 1978-07-28
IE39831L (en) 1975-04-30
YU289774A (en) 1983-01-21
DE2451417C3 (de) 1981-01-29
FR2248841A1 (cs) 1975-05-23
IL45675A (en) 1978-10-31
PH10519A (en) 1977-05-26
CH610892A5 (cs) 1979-05-15
AU7295474A (en) 1976-03-11
DE2451417B2 (de) 1980-05-14
DD119231A5 (cs) 1976-04-12
FI59402C (fi) 1981-08-10
FI315774A7 (cs) 1975-05-01
ES431454A1 (es) 1976-10-16
FI59402B (fi) 1981-04-30
CH611282A5 (cs) 1979-05-31
CA1029377A (en) 1978-04-11
DK134345B (da) 1976-10-25
HU168797B (cs) 1976-07-28
SE412389B (sv) 1980-03-03
AR205004A1 (es) 1976-03-31
US3963716A (en) 1976-06-15
LU71191A1 (cs) 1975-04-17
IN139552B (cs) 1976-07-03
DE2451417A1 (de) 1975-05-07
GB1459606A (en) 1976-12-22
DK561874A (cs) 1975-07-07
DK134345C (cs) 1977-03-21

Similar Documents

Publication Publication Date Title
SE7413530L (cs)
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES422001A1 (es) Un procedimiento para la preparacion de nuevas imidazotria-zinas.
EG11259A (en) Preparation of pharmacologically active compounds as depresent for histamin recepters
IE41528L (en) Furfuryl-benzomorphane derivatives.
ES8301990A1 (es) Un procedimiento para la preparacion de acidos 1, carbadestiapen-2-em-3-carboxililos 2- y 6- sustituidos.
ES421430A1 (es) Procedimiento para producir derivados carbostirilo.
SE7408498L (cs)
ES411112A1 (es) Procedimiento de preparacion de nuevos derivados del 1'1- difenil-etileno.
ES416891A1 (es) Un procedimiento de preparacion de derivados de acido suc- cinico.
IE41767L (en) Dihydroergopeptine derivatives
GB1084700A (en) Thiosemicarbazones and their production
ES537541A0 (es) Acidos 1, 3-dioxan-4-ilalquenoicos
GB1284379A (en) Substituted 4,5-diphenyloxazoles
ES427115A1 (es) Procedimiento de preparacion de nuevos derivados del acido acetico.
ES466192A1 (es) Procedimiento para la obtencion de derivados de la isoqui- noleina.
GB1459518A (en) Process for the preparation of bicyclo 4,3,0-nonenols
ES448389A1 (es) Procedimiento para la preparacion de isotiazolilureas susti-tuidas.
IE41201B1 (en) Cyclohexane tetrols and derivatives there of
GB1433103A (en) Pharmacologically active pyrrolodiazepines
GB1112909A (en) Ergoline derivatives
ES419386A1 (es) Un procedimiento para la preparacion de nuevos derivados deindenopirrol.
GB1441873A (en) Diamino-benzophenones
ES401174A1 (es) Procedimiento para la preparacion de nuevos esteres alcohi-licos del acido tiolcarbamidico basicamente sustituidos.
ES8203331A1 (es) Un procedimiento para la preparacion de derivados de tirosi-na.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7413530-2

Effective date: 19880627

Format of ref document f/p: F